ComplianceOnline

Register

Toll Free: +1-888-717-2436

CART 0

Your Shopping Cart

Contains 0 items
Total: $0.00
View Shopping Cart
Cart Image



The Benefit/Risk Ratio: Pharmacovigilance, Medical And Regulatory Converge: 2-Day Workshop

By:
Marco Anelli, R&D Director at Keypharma srl - Product Life Group
Location:-
Zurich, Switzerland
| Thursday, December 15, 2016 | Friday, December 16, 2016

Course Description:

In this two day workshop conference we will review requirements of EMA and EU regulatory authorities. The course will focus on the laws and regulations for Pharmacovigilance during Pre-marketing and Post-marketing (EMA, GVP, ICH). Attendees will get different points of views on Regulatory, Scientific, Ethical, Marketing and understanding about the role of GVP (Good Vigilance Practice). You will learn to design complete strategy for PSUR/PBRER.

Risk Based Audits of the PV system and Quality System. The course will focus on the design of the PV audit strategy, identification of the PV processes and entities subject to PV audit (define the PV audit universe), development of risk assessment methodology, development of procedures/tools to monitor PV processes and activities, and implementation of the PV audit strategy plan. Additionally, we will review methods of quality oversight and management of third parties performing PV activities.

The concept of “benefit/risk” ratio (no longer “risk/benefit”) has become the common denominator not only of pharmacovigilance (PV), but also of practically all drug-related regulatory activities, throughout the life cycle of a medicine, from preclinical to post-marketing.

This is a very scientifically sound approach and is also in line with the current clinical practice, however, it has made PV activities significantly more complex, since it implies that all data/information/knowledge about a drug have to be put in context before being analysed and acted upon.

The focus, in fact, has shifted from an “event-based” approach, i.e. making sure that all necessary data were properly and timely collected, to an approach in which the adequacy of information was somehow “taken for granted” and a much greater emphasis was placed on what could be done with such information.

As a matter of fact, in the past few years drug companies – especially the major ones – have been required to put a lot of effort and resources on activities like signal detection and signal management. In addition, Product Safety Update Reports (PSURs) and Risk Management Plans (RMPs), for a certain period considered essentially as “formalities”, have recently been analysed and criticized by Regulatory Authorities, in greater and greater depth.

This process - which could be summarized in the phrase “from data to knowledge to action” - has continued in the following years, too.
The RMP and the PSUR can be also considered as a “proactive PV” attempt, since it gives great importance not only to what we know about a drug, but also to what we do not know and to what can be done to minimize the possible consequences and/or to fill the gaps.

The preparation of such documents – in the most consistent and cost/effective way - now requires a relevant level of cooperation among the different departments of a Pharma company, and a “knowledge base” (vs. a “data based”) approach, which is the object of this two-day course.



Learning Objectives:

Upon completing this course participants should:

  • Understand the concept of benefit/risk (B/R) ratio, also in the light of the existing EU regulations
  • Evaluate the data/information available on the B/R ratio of a drug
  • Critically examine the different “Regulatory” and “Pharmacovigilance” documents pertaining to the different phases of the life cycle of a drug.
  • Perform a “gap analysis” of the existing documentation
  • Plan the different phases of the preparation of a PSUR/RMP


Who Will Benefit:

This course is designed for people involved in the preparation/supervision/coordination of the regulatory/PV documents pertaining the different phases of the life cycle of a drug, in particular:

  • Medical Affairs
  • Medical Departments
  • Regulatory Affairs
  • Pharmacovigilance
  • Medical Writing

Seminar Fee Includes:

Lunch
AM-PM Tea/Coffee
Seminar Material
USB with seminar presentation
Hard copy of presentation
Attendance Certificate
$100 Gift Cert for next seminar





Course Outline:

Day One (8:30 AM – 5:00 PM) Day Two (8:30 AM – 4:30 PM)

Registration Process: 8:30 AM – 9:00 AM
Session Start Time: 9:00 AM

THE BENEFIT RISK RATIO

  1. The Benefit-risk ratio: definition
    1. An ever-changing situation
    2. The position of EMA and EU regulatory authorities
  2. Pharmacovigilance:
    1. Definition
    2. Laws and regulations
      1. Pre-marketing
      2. Post-marketing (EMA, GVP, ICH)
    3. Different points of views:
      1. Regulatory
      2. Scientific
      3. Ethical
      4. Marketing
  3. The role of GVP (Good Vigilance Practice)
    1. Definitions
    2. Efficacy and effectiveness: from trials to real world
    (guided group activity/test)
  4. Overview of regulatory documentation on benefit-risk ratio:
    1. Investigator’s Brochure
    2. DSUR
    3. Clinical Trial Report
    4. CTD (Module 2.5 Clinical Overview and Addendum to the Clinical Overview)
    5. RMP
    6. PBRER/PSUR
    7. Clinical trial report
  5. Referrals
    1. The background
    2. Different types
    3. How to approach a referral
  6. Advantages of a unified “knowledge management” approach
    1. From data to knowledge
    2. From knowledge to documents
    3. The CCDS/CCSI
  7. Sources of data:
    1. Internal database(s)
    2. Literature
    3. Clinical trials
    4. How to collect information
    5. Simple stats and meta-analyses
      1. Evidence levels
      2. Free tools
  8. Practical exercise (real-life example from participants are welcome)

FOCUS ON THE PBRER/PSUR and RMP

  1. Again on sources of information (and their usefulness):
    1. Internal databases
    2. Clinical trials
    3. Literature
      1. AHFS
      2. Martindale
      3. PubMED
      4. Google Scholar
      5. Medline
      6. EMBASE
      7. Toxnet
      8. RTECS
  2. The new approach to Literature Searches
    1. Medical Literature Monitoring
  3. Literature reviews
    1. Cochrane reviews
  4. Signal detection
    1. A necessary tools
    2. Possible approaches
  5. Structure and contents of PSUR
    1. Detailed analysis
  6. PSUR-RMP comparison
  7. PSUR/ Addendum to Clinical Overview comparison
  8. How to analyse a PSUR
    1. What should be in there
    2. Two “real life” examples
  9. How to prepare a PSUR:
    1. The knowledge based approach
  10. How to prepare a PSUR:
    1. Checklist(s)
  11. How to prepare a PSUR:
    1. General considerations
    2. “image” considerations
  12. From theory to reality
    1. How to prepare a PSUR:
      1. Planning
      2. “project management”
  13. Practical exercise




Meet Your Instructor

Marco Anelli,
R&D Director at Keypharma srl - Product Life Group

Marco Anelli has been appointed in January 2016 "Head of Pharmacovigilance and Medical Affairs Advisory Services" at Product Life Group, an international consultancy company.

Prior to this, Marco was working as R&D Director at Keypharma, an Italy-based ProductLife Group company, and was responsible for the coordination of all clinical and preclinical aspects of projects run internally and on behalf of clients.

Drawing on a career in the pharmaceutical industry that spans 25 years, Marco provides expert oversight on a wide range of R&D and Medical Affairs related activities. Marco has participated in and coordinated all stages of drug development -- from formulation to Phase I-IV and pharmacovigilance. In addition, Marco is a qualified QPPV and has prepared and overseen more than 200 non-clinical and clinical overviews and summaries.

Before joining Keypharma and PLG, Marco was Medical Affairs Director at Eurand. In recent years, has worked extensively in the fields of pharmacoeconomics and health technology assessment. He has a medical degree from Milan University, specializations in Medical Statistics and Clinical Pharmacology from Pavia University and an international master's degree in health economics and pharmacoeconomics from Pompeu Fabra University in Barcelona.





Register Online

$1,899.00

Seminar One Registration (USD)

December 15-16, 2016, Zurich, Switzerland
(For Registrations till October 5, 2016 - $1899)
(For Registrations till November 10, 2016 - $1999)
(For Registrations till November 30, 2016 - $2099)
(For Registrations after November 30, 2016 - $2199)

$8,799.00
$11,394.00
You Save: $2,595.00 (22%)*

Special Group Discount Register for Six attendees (USD)

December 15-16, 2016, Zurich, Switzerland
*Hurry! This option is limited and based on availability.
Great Saving with Group Ticket!!! Only 3 left



Early bird seats are limited and based on first-come, first-serve.

Your registration fee includes the workshop, all course materials and lunch.


For discounts on multiple registrations, contact customer care at +1-888-717-2436.

Register by P.O. / Check


Yes, I want to attend "The Benefit/Risk Ratio: Pharmacovigilance, Medical And Regulatory Converge: 2-Day Workshop".

If you are paying by check:

Checks should be payable to MetricStream Inc. (our parent company) and mailed to:
2479 East Bayshore Road
Suite 200
Palo Alto, CA 94303
USA

Group Registrations

Significant tuition discounts are available for teams of two or more from the same company. You must register at the same time and provide a single payment to take advantage of the discount.

2 Attendees - Get 10% off
3 to 6 Attendees - Get 20% off
7 to 10 Attendees - Get 25% off
10+ Attendees - Get 30% off

Register by Wire Transfer




Terms & Conditions to Register for the Seminar/Conference/Event

Your registration for the seminar is subject to following terms and conditions. If you need any clarification before registering for this seminar please call us @ +1-888-717-2436 or email us @ editor@complianceonline.com

Payment:
Payment is required 2 days before the date of the conference. We accept American Express, Visa and MasterCard. Make checks payable to MetricStream Inc. (our parent company).

Cancellations and substitutions:
Written cancellations through fax or email (from the person who has registered for this conference) received at least 10 calendar days prior to the start date of the event will receive a refund — less a $300 administration fee. No cancellations will be accepted — nor refunds issued — within 10 calendar days before the start date of the event.

On request by email or fax (before the seminar) a credit for the amount paid minus administration fees ($300) will be transferred to any future ComplianceOnline event and a credit note will be issued.

Substitutions may be made at any time. No-shows will be charged the full amount.

We discourage onsite registrations, however if you wish to register onsite, payment to happen through credit card immediately or check to be submitted onsite. Conference material will be given on the spot if it is available after distributing to other attendees. In case it is not available, we will send the material after the conference is over.

In the event ComplianceOnline cancels the seminar, ComplianceOnline is not responsible for any airfare, hotel, other costs or losses incurred by registrants. Some topics and speakers may be subject to change without notice.

Attendance confirmation and documents to carry to the seminar venue:
After we receive the payment from the registered attendee, an electronic event pass will be sent to the email address associated with the registrant 5 working days before the seminar date. Please bring the pass to the venue of the event.

Conference photograph / video:
By registering and attending ComplianceOnline conference, you agree to have your photographs or videos taken at the conference venue and you do not have any objections to ComplianceOnline using these photos and videos for marketing, archiving or any other conference related activities. You agree to release ComplianceOnline from any kind of claims arising out of copyright or privacy violations.

Venue

Location:

View Larger Map




Media Partners

Sponsors


Partners



Media Partner Benefits
  • Logo and company data on the event website.
  • Logo on the conference material distributed during the conference.
  • Media Partner’s brochure distributed along with conference material.
  • Logo on all the mailings before and after the event.
  • 10% discount to media partner's subscribers.


Media Partner to do
  • Banner (min 728x90 or 468x60) on the Media Partner website.
  • Insertion of the event in the event calendar, both printed and/or online.
  • Announcement article of the conference on the Magazine and/or Website.
  • Dedicated email blast to all subscribers of Media Partner.
  • Article on the Magazine and/or Website after the conference.






Local Attractions

The Kunsthaus is Zurich's most important art museum and one of the most famous in Europe. Although the collection of the Kunsthaus Zürich ranges from Ancient times to the Victorian Era, the Swiss art museum is most noted for its modern and contemporary works from the 19th and 20th centuries. Top exhibits include the Giacometti wing and Rodin's Gate of Hell.




Widely known as the principal boulevard in Zürich, the Bahnhofstrasse is Zurich's most famous shopping street. Lined with some of the city's most elegant boutiques and top department stores, the Bahnhofstrasse offers a delightful place for a day of shopping amongst some of the world's greatest luxury brands and jewelry stores.




Elephants, rhinos, tigers, penguins and 20 species of monkeys are just some of the more than 360 animal species that can be admired at the Zurich Zoo. In the Masoala Rainforest Hall visitors can experience a piece of Madagascar first hand. A must-see for young and old.




Switzerland's Limmat River is actually part of the Linth river, which continues from Lake Zurich. Zurich is the most famous city located along the Limmat Valley and the Limmat River provides a charming and beautiful waterway to explore the sights of Zurich by boat.




The Fraumünster Church overlooks one of Zurich's oldest squares and markets, the Münsterhof. Tracing its founding back to 853, when it was a Benedictine abbey, the church is home to five famous stained-glass windows by renowned artist Marc Chagall.




Zurich Old Town (Altstadt ) is a cultural, social and historical melting pot. The highest concentration of clubs in Switzerland, one of the most famous shopping miles, and a plethora of cultural offerings




The Schweizerisches Landesmuseum (or Swiss National Museum in English) occupies an imposing neo-Gothic building, which houses a huge collection of objects documenting the Swiss peoples and their history. The collections range in date from prehistoric to modern times.






Follow us :
We need below information to serve you better